HBV PGRNA STATUS CAN REVEAL THE LONG-TERM PROGNOSES OF CHRONIC HEPATITIS B PATIENTS TREATED WITH NUCLEOS(T)IDE ANALOGUES

被引：0
|
作者：
Luo, Hao [1 ]
Tan, Ning [1 ]
Kang, Qian [1 ]
Pan, Jiali [1 ]
Xu, Xiaoyuan [2 ]
机构：
[1] Peking Univ, Hosp 1, Beijing, Peoples R China
[2] Peking Univ, Hosp 1, Infect Dis, Beijing, Peoples R China
来源：
HEPATOLOGY | 2019年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
651
引用
收藏
页码：408A / 408A
页数：1
相关论文
共 50 条
  • [1] Hepatitis B virus pregenomic RNA status can reveal the long-term prognoses of chronic hepatitis B patients treated with nucleos(t)ide analogues
    Luo, Hao
    Tan, Ning
    Kang, Qian
    Pan, Jiali
    Chen, Hongyu
    Xi, Hongli
    Yu, Min
    Xu, Xiaoyuan
    JOURNAL OF VIRAL HEPATITIS, 2020, 27 (03) : 323 - 328
  • [2] The application of novel HBV pgRNA assay to predict HBeAg clearance on long-term nucleos (t)ide analogues
    Shah, Pir Ahmad
    Rajab, Idriss
    Choudhry, Saad
    Gersch, Jeffrey
    Malladi, Vijayram
    Ishtiaq, Rizwan
    Kuhns, Mary
    Cloherty, Gavin
    Lau, Daryl
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E262 - E263
  • [3] RISK OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B PATIENTS TREATED WITH NUCLEOS(T)IDE ANALOGUES AND LONG-TERM VIROLOGICAL SUPPRESSION
    Fasano, M.
    Montrano, L.
    Ciarallo, M.
    Caccianotti, B.
    Giammario, A.
    Gioacchino, A.
    Santantonio, T.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S335 - S335
  • [4] Efficacy and safety of long-term therapy with nucleos(t)ide analogues in chronic hepatitis B
    Ibragimov, E. K.
    Abdurakhmanov, D. T.
    Rozina, T. P.
    Nikulkina, E. N.
    Tanaschuk, E. L.
    Odintsov, A., V
    Panevkina, S., V
    Moiseev, S., V
    TERAPEVTICHESKII ARKHIV, 2019, 91 (02) : 40 - 47
  • [5] Comorbidities in chronic hepatitis B patients currently treated with nucleos(t)ide analogues
    Siakavellas, S.
    Goulis, I.
    Manolakopoulos, S.
    Triantos, C.
    Kalliopi, Z.
    Tsentemidou, E.
    Kranidioti, H.
    Zisimopoulos, K.
    Tsoulas, C.
    Dalekos, G.
    Papatheodoridis, G.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S492 - S492
  • [6] HBV Vaccine Escape Mutations in a Chronic Hepatitis B Patient Treated with Nucleos(t)ide Analogues
    Sayan, Murat
    Bugdaci, Mehmet Sait
    MIKROBIYOLOJI BULTENI, 2013, 47 (03): : 544 - 549
  • [7] Benefits of long-term therapy with nucleos(t)ide analogues in treatment-naive patients with chronic hepatitis B
    Wei, Lai
    Kao, Jia-Horng
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (03) : 495 - 504
  • [8] The predictive value of serum HBV RNA level in chronic hepatitis B patients treated with nucleos (t)ide analogues
    Song, Yuxuan
    Xie, Yandi
    Zhang, Xiaojing
    Li, Rongkuan
    Zheng, Sujun
    Zhang, Shuyun
    Li, Ping
    Dai, Erhei
    Duan, Xuefei
    Liu, Juan
    Feng, Bo
    Lu, Fengmin
    JOURNAL OF HEPATOLOGY, 2024, 80 : S769 - S769
  • [9] MINIMAL RESIDUAL VIREMIA DURING LONG-TERM THERAPY WITH NUCLEOS(T)IDE ANALOGUES IN PATIENTS WITH CHRONIC HEPATITIS B
    Wiegand, Johannes
    Maier, Melanie
    Liebert, Uwe G.
    Berg, Thomas
    HEPATOLOGY, 2011, 54 : 1086A - 1086A
  • [10] LONG-TERM ANTIVIRAL EFFECT OF ENTECAVIR IN CHRONIC HEPATITIS B PATIENTS WITH PRIOR EXPOSURE TO NUCLEOS(T)IDE ANALOGUES
    Chen, Chien-Hung
    Wang, Jing-Houng
    Lu, Sheng-Nan
    Hu, Tsung-Hui
    Hung, Chao-Hung
    Lee, Chuan-Mo
    HEPATOLOGY, 2011, 54 : 1035A - 1035A
12345